ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/19 | 3,470 | 3,490 | 3,390 | 3,405 | -115 | -3.3% | 133,500 |
2021/02/18 | 3,460 | 3,530 | 3,430 | 3,520 | +95 | +2.8% | 165,800 |
2021/02/17 | 3,500 | 3,505 | 3,420 | 3,425 | -100 | -2.8% | 147,300 |
2021/02/16 | 3,440 | 3,540 | 3,420 | 3,525 | +70 | +2% | 170,900 |
2021/02/15 | 3,420 | 3,475 | 3,395 | 3,455 | +55 | +1.6% | 169,800 |
2021/02/12 | 3,425 | 3,430 | 3,385 | 3,400 | +30 | +0.9% | 217,100 |
2021/02/10 | 3,365 | 3,395 | 3,335 | 3,370 | -30 | -0.9% | 215,600 |
2021/02/09 | 3,505 | 3,510 | 3,365 | 3,400 | -115 | -3.3% | 309,900 |
2021/02/08 | 3,560 | 3,560 | 3,345 | 3,515 | -50 | -1.4% | 432,900 |
2021/02/05 | 3,500 | 3,595 | 3,475 | 3,565 | +100 | +2.9% | 272,800 |
2021/02/04 | 3,470 | 3,500 | 3,460 | 3,465 | -5 | -0.1% | 89,500 |
2021/02/03 | 3,420 | 3,485 | 3,420 | 3,470 | +55 | +1.6% | 93,600 |
2021/02/02 | 3,390 | 3,415 | 3,370 | 3,415 | +5 | +0.1% | 115,100 |
2021/02/01 | 3,395 | 3,425 | 3,395 | 3,410 | +5 | +0.1% | 135,100 |
2021/01/29 | 3,420 | 3,490 | 3,400 | 3,405 | -50 | -1.4% | 179,600 |
2021/01/28 | 3,410 | 3,470 | 3,395 | 3,455 | +35 | +1% | 561,800 |
2021/01/27 | 3,405 | 3,465 | 3,405 | 3,420 | +50 | +1.5% | 153,400 |
2021/01/26 | 3,390 | 3,430 | 3,370 | 3,370 | -25 | -0.7% | 144,100 |
2021/01/25 | 3,375 | 3,410 | 3,360 | 3,395 | +50 | +1.5% | 174,000 |
2021/01/22 | 3,390 | 3,390 | 3,330 | 3,345 | -115 | -3.3% | 141,700 |
2021/01/21 | 3,435 | 3,480 | 3,420 | 3,460 | +55 | +1.6% | 157,800 |
2021/01/20 | 3,360 | 3,410 | 3,340 | 3,405 | +60 | +1.8% | 123,600 |
2021/01/19 | 3,355 | 3,360 | 3,315 | 3,345 | -10 | -0.3% | 120,800 |
2021/01/18 | 3,475 | 3,505 | 3,345 | 3,355 | -90 | -2.6% | 156,300 |
2021/01/15 | 3,455 | 3,480 | 3,435 | 3,445 | +40 | +1.2% | 204,200 |
2021/01/14 | 3,355 | 3,415 | 3,335 | 3,405 | +30 | +0.9% | 210,400 |
2021/01/13 | 3,330 | 3,380 | 3,330 | 3,375 | +30 | +0.9% | 191,800 |
2021/01/12 | 3,285 | 3,355 | 3,275 | 3,345 | +45 | +1.4% | 186,000 |
2021/01/08 | 3,235 | 3,305 | 3,230 | 3,300 | +80 | +2.5% | 176,400 |
2021/01/07 | 3,200 | 3,240 | 3,185 | 3,220 | +85 | +2.7% | 206,500 |
2021/01/06 | 3,125 | 3,185 | 3,125 | 3,135 | +25 | +0.8% | 106,800 |
2021/01/05 | 3,060 | 3,115 | 3,060 | 3,110 | +15 | +0.5% | 108,000 |
2021/01/04 | 3,130 | 3,135 | 3,075 | 3,095 | -5 | -0.2% | 111,100 |
2020/12/30 | 3,145 | 3,145 | 3,090 | 3,100 | -45 | -1.4% | 110,600 |
2020/12/29 | 3,065 | 3,145 | 3,055 | 3,145 | +80 | +2.6% | 132,300 |
2020/12/28 | 3,085 | 3,115 | 3,045 | 3,065 | -5 | -0.2% | 120,400 |
2020/12/25 | 3,060 | 3,095 | 3,055 | 3,070 | +25 | +0.8% | 81,200 |
2020/12/24 | 3,080 | 3,100 | 3,035 | 3,045 | -45 | -1.5% | 145,600 |
2020/12/23 | 3,120 | 3,140 | 3,080 | 3,090 | -25 | -0.8% | 166,100 |
2020/12/22 | 3,180 | 3,180 | 3,095 | 3,115 | -80 | -2.5% | 161,400 |
2020/12/21 | 3,250 | 3,250 | 3,180 | 3,195 | -40 | -1.2% | 112,000 |
2020/12/18 | 3,205 | 3,250 | 3,205 | 3,235 | -20 | -0.6% | 164,700 |
2020/12/17 | 3,290 | 3,290 | 3,235 | 3,255 | -10 | -0.3% | 128,900 |
2020/12/16 | 3,330 | 3,330 | 3,250 | 3,265 | -35 | -1.1% | 106,500 |
2020/12/15 | 3,290 | 3,320 | 3,255 | 3,300 | -10 | -0.3% | 130,500 |
2020/12/14 | 3,300 | 3,345 | 3,295 | 3,310 | -20 | -0.6% | 91,300 |
2020/12/11 | 3,290 | 3,350 | 3,290 | 3,330 | +60 | +1.8% | 168,300 |
2020/12/10 | 3,215 | 3,280 | 3,210 | 3,270 | +35 | +1.1% | 156,500 |
2020/12/09 | 3,230 | 3,245 | 3,180 | 3,235 | +65 | +2.1% | 120,000 |
2020/12/08 | 3,125 | 3,185 | 3,120 | 3,170 | +50 | +1.6% | 128,600 |
1051~
1100
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム